Skin and Soft Tissue Infections Flashcards

1
Q

Differentiate between impetigo and ecthyma

A

Impetigo is a superficial infection of skin characterized by pustules / vesicles progressing to crusting

Ecthyma is a deeper variant of vesicles/pustules that evolve into punched out ulcer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define what is erysipelas

A

Erysipelas is a more superficial infection of skin involving lymphatics and are characterized by tender, erythematous plaque with well-demarcated borders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define a furuncle and carbuncle

A

Furuncle is an infection of the hair follicle with small subcutaneous abscess

Carbuncles a collection of furuncles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are some of the host defense mechanisms? Therefore, describe the pathogenesis of SSTI.

A

Host defense mechanism
1. Skin act as physical, chemical and immunological barrier.
2. Continuous renewal of epidermal layer –> shedding of keratocytes and skin microbiota
3. Sebaceous secretion: inhibit growth of bacteria and fungi
4. Normal commensal skin microbiome: prevent colonization and overgrowth of pathogenic strains

Disruption of normal host defenses leads to an overgrowth and invasion of skin and soft tissues by pathogenic microorganisms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

List some of the risk factors associated with SSTI

A

Disruption of skin barrier
- Traumatic: lacerations, recent surgery, burns, abrasions, crush injuries
- Non traumatic: ulcer, tinea pedis, toe web intertigo, chemical irritants
- Impaired venous and lymphatic drainage: sapheous vasectomy, obesity, chronic venous insufficiency

Conditions predisposing infections: DM, Cirrhosis, Neutropenia, HIV, Immunosuppressive and transplantation

History of cellulitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is some advice you can counsel a patient should they have any of the risk factors, to prevent SSTI?

A

Manage current predisposing risk factors (e.g. treat tinea pedis)

Prevent dry and cracked skin

Good foot care for DM patients to prevent wound and ulcers

Good wound care to maintain skin integrity by treating acute traumatic wounds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is some advice you can counsel a patient should they have any of the risk factors, to prevent SSTI?

A

Manage current predisposing risk factors (e.g. treat tinea pedis)

Prevent dry and cracked skin

Good foot care for DM patients to prevent wound and ulcers

Good wound care to maintain skin integrity by treating acute traumatic wounds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Using the systematic approach, how do I confirm the presence of an SSTI infection?

A

Acknowledge the risk factors through history taking and checking for underlying disease; recent trauma, bites, burns and water exposure; animal exposure; travel history.

Diagnose with swab culture and blood culture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

When is a blood culture indicated?

A

Severe cases with marked systemic signs of infection

Immunocompromised patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Is swab cultures always necessary?

A

No. Mild superficial infections do not need a swab culture.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How should a swab culture be collected?

A

Deep in wound after surface is cleansed

Base of closed abscess

Curettage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is a telltale sign that differentiates between an impetigo and ecthyma?

A

Impetigo have dried discharge forming honey crust on erythematous base and are well localised lesions

Ecthyma are lesions extending through epidermis and deep into dermis. A significant sign would be pruritus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the differences between erysipelas and cellulitis?

A

Erysipelas usually located in lower extremities of the upper dermis. They are painful plaques raised above skin and have well-demarcated edges

Cellulitis usually found in lower extremities and are non-elevated, acute and diffuse, can spread thus have poor demarcation. They are unilateral as well

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Identify the type of pathogen associated with impetigo

A

Staphylococci
Streptococci

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Identify the type of pathogen associated with ecthyma

A

Group A streptococcus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are some nonpurulent SSTI?

A

Cellulitis
Erysipelas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Identify the type of pathogens associated with non-purulent SSTI

A

Group A Streptococcus

RARE: S.Aureus and Psuedomonas if have water exposure

17
Q

What are some purulent SSTI?

A

Cellulitis
Skin abscess
Carbuncles
Furuncles

18
Q

List the pathogens associated with purulent SSTI.

A

S.Aureus (mainly)
Group A Streptococcus
CA-MRSA (US) and HA-MRSA (US & SG)

19
Q

What is the treatment and duration for mild, limiting impetigo? Why is the use of this agent generally not recommended?

A

Topical mupirocin BD for 5 days
Generally not needed because the condition is self-limiting. While it is effective against aerobic gram positive cocci, it is not effective against enterococci and gram negatives.
Also potential increase in resistance in MRSA

20
Q

For impetigo and ecthyma, what is the empiric therapy and duration to initiate?

A

PO Cephalexin 500mg q6h / PO Cloxacillin 500mg - 1g q6h for 7 days

21
Q

If a patient has beta lactam allergy, what is an alternative empiric therapy to consider for impetigo and ecthyma

A

PO Clindamycin 300-450mg q6h

22
Q

Upon receiving AST results, what is the culture directed therapy for Staphylococcus impetigo and ecthyma?

A

PO Cephalexin 500mg q6h / PO Cloxacillin 500-1g q6h

23
Q

Upon receiving AST results, what is the culture directed therapy for S.pyogenes impetigo and ecthyma?

A

PO Penicillin V 500mg q6h / PO Amoxicillin 500mg - 1g q8h

24
Q

For purulent SSTI, how is an antibiotic therapy chosen?

A

Determine severity and route of treatment

Consider if empiric therapy is needed to cover the following

25
Q

What is the severity classification and choice of treatment for purulent SSTI?

A

Mild: I&D

Moderate (have systemic signs of infection): I&D and oral antibiotics
- Cephalexin
- Cloxacillin
- Penicillin allergy: Clindamycin

Severe: requires IV antibiotics and I&D
- Cefazolin 1-2g q8h
- Cloxacillin 500mg - 1g q4-6h
- Clindamycin 600mg q8h
- Vancomycin 15mg/kg/d

26
Q

If empiric therapy is needed to cover MRSA for purulent SSTI, what do I consider if the patient is in the US? What are some agents I can use?

A

Consider CA-MRSA
- Co-trimoxazole 960mg BD
- Doxycycline 100mg BD
- Clindamycin 300-450mg BD

27
Q

What is an agent I can use to target MRSA risk in Singapore for purulent SSTI?

A

Vancomycin

Daptomycin

Linezolid

28
Q

What empiric therapy can I consider for patients with Gram Negative and anaerobe risk factors?

A

Amoxicillin clavulanate 625mg TDS or 1g BD

29
Q

What is the ideal duration of treatment for antibiotics for those with purulent SSTI?

A

5-10 days

30
Q

When should I consider the need for antibiotics to treat SSTI?

A

Unable to drain completely
Lack of response to I&D
Extensive disease involving several sites
Extreme age
Immunosuppressed patients
Signs of systemic illness based on vital signs

31
Q

What is the severity classification for nonpurulent SSTI?

A

Mild: No signs of systemic infection

Moderate: Signs of systemic infection and some purulence

Severe; Signs of systemic infection, unable to tolerate oral therapy and immunocompromised

32
Q

How should I treat mild nonpurulent SSTI?

A

PO Penicillin V 500mg q6h
PO Cloxacillin 500mg - 1g q6h
PO Cephalexin 500mg q6h

33
Q

What is an alternative agent to treat mild and moderate SSTI if patient is allergic to beta lactams?

A

PO Clindamycin 300-450mg q6h

34
Q

How is moderate nonpurulent SSTI treatment different from that of mild SSTI?

A

Inclusion of MSSA coverage

35
Q

What is an agent to start for moderate non purulent SSTI?

A

IV Cefazolin 1-2g q8h

36
Q

What are some agents used to treat those with severe nonpurulent SSTI?

A

Piperacillin Tazobactam 4.5g q6-8h

Meropenem

Cefepime 2g q8h

37
Q

How long is the duration of therapy for those with nonpurulent SSTI?

A

5-10 days

38
Q

How long should I extend the duration of therapy for those who are immunocompromised and have nonpurulent SSTI?

A

14 days

39
Q

How should I advice an outpatient in treating their nonpurulent SSTI at home?

A

Ensure rest and limb elevation to allow drainage of edema and inflammatory substances

Treat underlying cause of nonpurulent SSTi

40
Q

What are some differential diagnosis of cellulitis?

A

Deep venous thrombosis
Calciphylaxis
Stasis dermatitis
Hematoma
Erythema migrans